SG10201809418VA - New administration routes of insulin, insulin analogs or derivatives of insulin - Google Patents
New administration routes of insulin, insulin analogs or derivatives of insulinInfo
- Publication number
- SG10201809418VA SG10201809418VA SG10201809418VA SG10201809418VA SG10201809418VA SG 10201809418V A SG10201809418V A SG 10201809418VA SG 10201809418V A SG10201809418V A SG 10201809418VA SG 10201809418V A SG10201809418V A SG 10201809418VA SG 10201809418V A SG10201809418V A SG 10201809418VA
- Authority
- SG
- Singapore
- Prior art keywords
- insulin
- derivatives
- administration routes
- analogs
- new administration
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
New Administration Routes of Insulin, Insulin Analogs or Derivatives of Insulin An insulin, insulin analog or derivative of insulin for use in the treatment of diabetes. 5 The use comprises new administration routes of insulin analogs. [Figure 1 and Figure 2]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14305613 | 2014-04-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201809418VA true SG10201809418VA (en) | 2018-11-29 |
Family
ID=50721731
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201809418VA SG10201809418VA (en) | 2014-04-25 | 2015-04-23 | New administration routes of insulin, insulin analogs or derivatives of insulin |
| SG11201607936QA SG11201607936QA (en) | 2014-04-25 | 2015-04-23 | New administration routes of insulin, insulin analogs or derivatives of insulin |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201607936QA SG11201607936QA (en) | 2014-04-25 | 2015-04-23 | New administration routes of insulin, insulin analogs or derivatives of insulin |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20170119856A1 (en) |
| EP (1) | EP3134110A1 (en) |
| JP (1) | JP2017514810A (en) |
| KR (1) | KR20160143856A (en) |
| CN (1) | CN106232137A (en) |
| AU (1) | AU2015250841A1 (en) |
| CA (1) | CA2944954A1 (en) |
| MX (1) | MX2016013979A (en) |
| RU (1) | RU2016146113A (en) |
| SG (2) | SG10201809418VA (en) |
| WO (1) | WO2015162201A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109718462B (en) * | 2017-10-27 | 2022-04-08 | 研能科技股份有限公司 | Liquid supply device for human insulin injection |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8465468B1 (en) * | 2000-06-29 | 2013-06-18 | Becton, Dickinson And Company | Intradermal delivery of substances |
| US20060264886A9 (en) * | 2002-05-06 | 2006-11-23 | Pettis Ronald J | Method for altering insulin pharmacokinetics |
| CN1859943B (en) * | 2002-10-11 | 2010-09-29 | 贝克顿·迪金森公司 | System for controlling concentration of glucose in a patient |
| BRPI0409984A (en) * | 2003-05-06 | 2006-05-09 | Becton Dickinson Co | process for changing insulin pharmacokinetics |
| CN101102725A (en) * | 2003-05-06 | 2008-01-09 | 贝克顿·迪金森公司 | A method for altering insulin pharmacokinetics |
| CN101951957A (en) * | 2008-01-04 | 2011-01-19 | 百达尔公司 | Insulin discharges the insulin preparation as the function of the glucose level of tissue |
| JP6119609B2 (en) * | 2011-10-28 | 2017-04-26 | 凸版印刷株式会社 | Hollow needle-like body manufacturing method, hollow needle-like body and hollow needle-like body liquid feeding system |
-
2015
- 2015-04-23 JP JP2016563106A patent/JP2017514810A/en active Pending
- 2015-04-23 SG SG10201809418VA patent/SG10201809418VA/en unknown
- 2015-04-23 EP EP15719657.7A patent/EP3134110A1/en not_active Withdrawn
- 2015-04-23 RU RU2016146113A patent/RU2016146113A/en not_active Application Discontinuation
- 2015-04-23 SG SG11201607936QA patent/SG11201607936QA/en unknown
- 2015-04-23 KR KR1020167032561A patent/KR20160143856A/en unknown
- 2015-04-23 CA CA2944954A patent/CA2944954A1/en not_active Abandoned
- 2015-04-23 MX MX2016013979A patent/MX2016013979A/en unknown
- 2015-04-23 WO PCT/EP2015/058775 patent/WO2015162201A1/en active Application Filing
- 2015-04-23 CN CN201580021906.4A patent/CN106232137A/en active Pending
- 2015-04-23 US US15/301,820 patent/US20170119856A1/en not_active Abandoned
- 2015-04-23 AU AU2015250841A patent/AU2015250841A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20170119856A1 (en) | 2017-05-04 |
| MX2016013979A (en) | 2017-01-11 |
| JP2017514810A (en) | 2017-06-08 |
| RU2016146113A3 (en) | 2018-12-20 |
| EP3134110A1 (en) | 2017-03-01 |
| KR20160143856A (en) | 2016-12-14 |
| SG11201607936QA (en) | 2016-11-29 |
| WO2015162201A1 (en) | 2015-10-29 |
| CN106232137A (en) | 2016-12-14 |
| AU2015250841A1 (en) | 2016-10-27 |
| CA2944954A1 (en) | 2015-10-29 |
| RU2016146113A (en) | 2018-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018256640A1 (en) | Stabilized pharmaceutical formulations of insulin analogues and/or insulin derivatives | |
| PH12016501809A1 (en) | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders | |
| SG10201809427SA (en) | Insulin receptor partial agonists | |
| CA2956871C (en) | Compounds active towards bromodomains | |
| MY189466A (en) | Methods of modulating drug plasma levels using erythrohydroxybupropion | |
| PH12017501486A1 (en) | Nasal powder formulation for treatment of hypoglycemia | |
| IL246757B (en) | Novel insulin derivatives and the medical uses hereof | |
| CL2015002835A1 (en) | New pyridine derivatives | |
| EP3275482A4 (en) | Syringe holder and medical solution administration set | |
| IL257173A (en) | Novel insulin derivatives and the medical uses hereof | |
| MX366636B (en) | Novel derivative of an insulin analogue. | |
| SA517390475B1 (en) | System of Multiple Bags and Method for The Preparation of Hemocomponents | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
| MX2016015261A (en) | Allisartan isoproxil solid dispersion and pharmaceutical composition thereof. | |
| PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
| PH12017501979A1 (en) | Pharmaceutical compound | |
| SG10201809418VA (en) | New administration routes of insulin, insulin analogs or derivatives of insulin | |
| PH12017500084A1 (en) | Vitamin b2 and its use | |
| MX2016010919A (en) | 4-benzylsulfonyl-2-butenenitrile. | |
| MX2017001512A (en) | Compounds active towards bromodomains. | |
| UA92917U (en) | Method for prevention of the asiderotic adynamia in piglets | |
| EA201692164A1 (en) | MEDICINE FOR THE TREATMENT OF PATIENTS WITH TINNITUS | |
| IN2014DE00822A (en) | ||
| MD20150017A2 (en) | Use of Polybiolin drug in patients with liver cirrhosis | |
| IN2014DE00818A (en) |